Therapeutic Drug Monitoring in Psychiatry – Positive Impact on Patients through Lab-Clinician Collaboration
Recorded at the IATDMCT Conference in September 2024
Description:
Therapeutic drug monitoring (TDM) is pivotal in ensuring patient safety and optimizing treatment outcomes in clinical practice. Fast turnaround times, result consistency and accuracy are critical for a successful implementation to deliver against current clinical needs. This session will highlight the clinical advantages of rapid turnaround times of clozapine measurement, which contributed to safer and more effective management of schizophrenia using the MyCare immunoassay. We will explore updated validation data on the assay’s accuracy and specificity and discuss the impact of inflammation on clozapine concentration. Key strategies for the successful implementation of TDM testing will also be discussed.
Presenting Faculty:
Dr. Vincent De Guire, Ph.D, DEPD, CSPQ
- Clinical biochemist, Maisonneuve-Rosemont Hospital, Optilab Montreal-CHUM laboratory network
- Associated researcher at Maisonneuve-Rosemont Hospital Research Center
- Clinical assistant professor at the University of Montreal
Additional Resources:
For additional handouts, questions, or inquiries, please contact hello@saladax.com or enter your email below!
